Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109319) titled 'A study to test if tenecteplase helps people to recover from an acute stroke when given more than 4.5 hours after the person was last seen well' on April 24.
Study Type: Interventional
Study Design:
Other Method of generating randomization sequence:Other Method of allocation concealment:Other Blinding and masking:Open Label
Primary Sponsor: Boehringer Ingelheim International GmbH
Condition:
Health Condition 1: I63- Cerebral infarction
Intervention:
Intervention1: Tenecteplase: Dose: One single dose bolus administration
Route: i.v
Duration: 90 days
Control Intervention1: Standard of Care: Standard of ...